Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» MannKind's inhaled insulin Afrezza meets goals in 2 late-stage studies of diabetes patients
MannKind's inhaled insulin Afrezza meets goals in 2 late-stage studies of diabetes patients
MannKind's inhaled insulin Afrezza meets goals in 2 late-stage studies of diabetes patients
Submitted by
admin
on August 14, 2013 - 9:17am
Source:
Yahoo/AP
News Tags:
insulin
diabetes MannKind
Afrezza
inhaled insulin
Headline:
MannKind's inhaled insulin Afrezza meets goals in 2 late-stage studies of diabetes patients
Do Not Allow Advertisers to Use My Personal information
